Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

por Elfiky, Abdo A.
Publicado 2020

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

por Elfiky, Abdo A.
Publicado 2020

Ebola virus glycoprotein GP1—host cell-surface HSPA5 binding site prediction

por Elfiky, Abdo A.
Publicado 2020

Reply to a letter to the editor

por Elfiky, Abdo A.
Publicado 2020

SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses

por Elfiky, Abdo A.
Publicado 2020

Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020...

por Elfiky, Abdo A.
Publicado 2020

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective

por Elfiky, Abdo A
Publicado 2022

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study

por Elfiky, Abdo A., Elshemey, Wael M.
Publicado 2016

SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic

por Ismail, Alaa M., Elfiky, Abdo A.
Publicado 2020

Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico

por Elfiky, Abdo A, Ibrahim, Ibrahim M
Publicado 2021

Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view

por Elfiky, Abdo A, Ibrahim, Ibrahim M
Publicado 2022

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective

por Abduljalil, Jameel M., Elfiky, Abdo A.
Publicado 2022

GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective

por Elgohary, Alaa M., Elfiky, Abdo A., Barakat, Khaled
Publicado 2021

Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico

por Abduljalil, Jameel M., Elfiky, Abdo A., Elgohary, Alaa M.
Publicado 2023

GRP78: A cell's response to stress

por Ibrahim, Ibrahim M., Abdelmalek, Doaa H., Elfiky, Abdo A.
Publicado 2019

The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico

por Elfiky, Abdo A., Azzam, Eman B., Shafaa, Medhat W.
Publicado 2021

Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective

por Ibrahim, Ibrahim M., Elfiky, Abdo A., Elgohary, Alaa M.
Publicado 2021

SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective

por Elfiky, Abdo A., Ibrahim, Ibrahim M., Elgohary, Alaa M.
Publicado 2022

Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective

por Abosheasha, Mohammed A., El-Gowily, Afnan H., Elfiky, Abdo A.
Publicado 2021

COVID-19 spike-host cell receptor GRP78 binding site prediction

por Ibrahim, Ibrahim M., Abdelmalek, Doaa H., Elshahat, Mohammed E., Elfiky, Abdo A.
Publicado 2020